Helmut Schaider
Impact in
- Oncology top 2%
- Cutaneous Melanoma Detection and Management
- Chemokine receptors and signaling
- Cancer Cells and Metastasis
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Oncology 39
- Cutaneous Melanoma Detection and Management 17
- Chemokine receptors and signaling 7
- Cancer Cells and Metastasis 6
-
- Melanoma and MAPK Pathways 8
- RNA Interference and Gene Delivery 7
- Co-authors
- Meenhard Herlyn (16 shared papers)Mark E. Nesbit (4 shared papers)Beate Rinner (12 shared papers)Kapaettu Satyamoorthy (4 shared papers)Heinz Hammerlindl (10 shared papers)H. Peter Soyer (29 shared papers)Dagmar Zweytick (7 shared papers)Sabrina Riedl (7 shared papers)
- Journals
- Journal of Investigative Dermatology (5 papers)British Journal of Dermatology (4 papers)Oncotarget (3 papers)PLoS ONE (2 papers)Annals of Oncology (2 papers)
- Partner nations
- AustraliaAustriaUnited States
In The Last Decade
Helmut Schaider
80 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 117
- Oncology 981
- Immunology 669
- Immunology and Allergy 142
- Microbiology 152
- Toxicology 78
Countries citing papers authored by Helmut Schaider
This map shows the geographic impact of Helmut Schaider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helmut Schaider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helmut Schaider more than expected).
Fields of papers citing papers by Helmut Schaider
This network shows the impact of papers produced by Helmut Schaider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helmut Schaider. The network helps show where Helmut Schaider may publish in the future.
Co-authors
The 25 scholars most cited alongside Helmut Schaider, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 274 | |
| 2 | 2001 | 188 | |
| 3 | 2001 | 151 | |
| 4 | 2002 | 137 | |
| 5 | Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling. | 2001 | 134 |
| 6 | 2014 | 127 | |
| 7 | 2011 | 125 | |
| 8 | 1992 | 119 | |
| 9 | 2000 | 91 | |
| 10 | 2008 | 82 | |
| 11 | 2012 | 72 | |
| 12 | 2021 | 69 | |
| 13 | 2019 | 64 | |
| 14 | 1997 | 63 | |
| 15 | 2012 | 59 | |
| 16 | 2017 | 57 | |
| 17 | 2007 | 47 | |
| 18 | 2015 | 46 | |
| 19 | 2016 | 45 | |
| 20 | 2017 | 43 |
About Helmut Schaider
Helmut Schaider is a scholar working on Oncology, Molecular Biology, Immunology, Cell Biology and Immunology and Allergy, having authored 83 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (17 papers), Immunotherapy and Immune Responses (10 papers), Melanoma and MAPK Pathways (8 papers), Cell Adhesion Molecules Research (8 papers), RNA Interference and Gene Delivery (7 papers), Chemokine receptors and signaling (7 papers), Cancer Cells and Metastasis (6 papers) and Antimicrobial Peptides and Activities (6 papers). The work is most often cited by research in Oncology (981 citations), Immunology (669 citations), Immunology and Allergy (142 citations), Microbiology (152 citations) and Toxicology (78 citations). Helmut Schaider has collaborated with scholars based in Australia, Austria and United States. Frequent co-authors include Meenhard Herlyn, Mark E. Nesbit, Beate Rinner, Kapaettu Satyamoorthy, Heinz Hammerlindl, H. Peter Soyer, Dagmar Zweytick, Sabrina Riedl, Karl Lohner and Thomas H. Miller. Their work appears in journals such as Journal of Investigative Dermatology, British Journal of Dermatology, Oncotarget, PLoS ONE and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.